BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11665599)

  • 1. Kinetic analysis of the action of P-site analogs.
    Dessauer CW
    Methods Enzymol; 2002; 345():112-26. PubMed ID: 11665599
    [No Abstract]   [Full Text] [Related]  

  • 2. Role of adenylate cyclase in immunologic release of mediators from rat mast cells: agonist and antagonist effects of purine- and ribose-modified adenosine analogs.
    Holgate ST; Lewis RA; Austen KF
    Proc Natl Acad Sci U S A; 1980 Nov; 77(11):6800-4. PubMed ID: 6256761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An ATP pool associated with adenyl cyclase of brain tissue.
    Shimizu H; Okayama H
    J Neurochem; 1973 Apr; 20(4):1279-83. PubMed ID: 4348984
    [No Abstract]   [Full Text] [Related]  

  • 4. Regulation of adenylate cyclase by adenosine: characterization of the P-site.
    Bushfield M; Johnson RA
    Biochem Soc Trans; 1990 Apr; 18(2):150-1. PubMed ID: 2379673
    [No Abstract]   [Full Text] [Related]  

  • 5. Isozyme-dependent sensitivity of adenylyl cyclases to P-site-mediated inhibition by adenine nucleosides and nucleoside 3'-polyphosphates.
    Johnson RA; Désaubry L; Bianchi G; Shoshani I; Lyons E; Taussig R; Watson PA; Cali JJ; Krupinski J; Pieroni JP; Iyengar R
    J Biol Chem; 1997 Apr; 272(14):8962-6. PubMed ID: 9083018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural and kinetic analyses of the interaction of anthrax adenylyl cyclase toxin with reaction products cAMP and pyrophosphate.
    Guo Q; Shen Y; Zhukovskaya NL; Florián J; Tang WJ
    J Biol Chem; 2004 Jul; 279(28):29427-35. PubMed ID: 15131111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of adenylyl cyclase activity by quantitative mass spectrometry.
    el-Shazley H; Newton RP; Harris FM; Brenton AG; Walton TJ; Restall CJ; Bayliss M; Wilkins A; Games DE; Langridge JI
    Biochem Soc Trans; 1996 Aug; 24(3):474S. PubMed ID: 8879018
    [No Abstract]   [Full Text] [Related]  

  • 8. The catalytic mechanism of mammalian adenylyl cyclase. Equilibrium binding and kinetic analysis of P-site inhibition.
    Dessauer CW; Gilman AG
    J Biol Chem; 1997 Oct; 272(44):27787-95. PubMed ID: 9346923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Two-metal-Ion catalysis in adenylyl cyclase.
    Tesmer JJ; Sunahara RK; Johnson RA; Gosselin G; Gilman AG; Sprang SR
    Science; 1999 Jul; 285(5428):756-60. PubMed ID: 10427002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adenylate cyclase from Trypanosoma gambiense.
    Walter RD; Nordmeyer JP; Königk E
    Hoppe Seylers Z Physiol Chem; 1974 Apr; 355(4):427-30. PubMed ID: 4373380
    [No Abstract]   [Full Text] [Related]  

  • 11. Enzymatic preparation of 32P-labeled beta-L-2',3',-dd-5'ATP and its use as a high-affinity, conformation-specific ligand for labeling adenylyl cyclases.
    Johnson RA; Shoshani I; Dessauer C; Gosselin G
    Nucleosides Nucleotides; 1999; 18(4-5):839-42. PubMed ID: 10432690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel mechanism for adenylyl cyclase inhibition from the crystal structure of its complex with catechol estrogen.
    Steegborn C; Litvin TN; Hess KC; Capper AB; Taussig R; Buck J; Levin LR; Wu H
    J Biol Chem; 2005 Sep; 280(36):31754-9. PubMed ID: 16002394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two distinct adenosine-sensitive sites on adenylate cyclase.
    Londos C; Wolff J
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5482-6. PubMed ID: 271970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of adenyl cyclase by an exotoxin of Bacillus thuringiensis.
    Grahame-Smith DG; Isaac P; Heal DJ; Bond RP
    Nature; 1975 Jan; 253(5486):58-60. PubMed ID: 163006
    [No Abstract]   [Full Text] [Related]  

  • 15. Lead-induced inhibition of brain adenyl cyclase.
    Nathanson JA; Bloom FE
    Nature; 1975 May; 255(5507):419-20. PubMed ID: 165434
    [No Abstract]   [Full Text] [Related]  

  • 16. Metal ion and guanine nucleotide regulation of the inhibition of lung adenylate cyclase by adenosine analogs.
    Welton AF; Simko BA
    Biochim Biophys Acta; 1980 Sep; 615(1):252-61. PubMed ID: 7426663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyclic nucleotides vs. adenosine analogs as inhibitors of adenylate cyclase activity: nonidentity of sites of action.
    Weinryb I; Michel IM
    Experientia; 1975 Aug; 31(8):892-4. PubMed ID: 169141
    [No Abstract]   [Full Text] [Related]  

  • 18. Crystal structure of the catalytic domains of adenylyl cyclase in a complex with Gsalpha.GTPgammaS.
    Tesmer JJ; Sunahara RK; Gilman AG; Sprang SR
    Science; 1997 Dec; 278(5345):1907-16. PubMed ID: 9417641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific inhibition of cyclic AMP-dependent protein kinase, adenylate cyclase and phosphodiesterase by ATP and cyclic AMP analogs.
    Severin ES; Gulyaev NN; Bulargina TV; Kochetkova MN
    Adv Enzyme Regul; 1978; 17():251-82. PubMed ID: 230707
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular basis for P-site inhibition of adenylyl cyclase.
    Tesmer JJ; Dessauer CW; Sunahara RK; Murray LD; Johnson RA; Gilman AG; Sprang SR
    Biochemistry; 2000 Nov; 39(47):14464-71. PubMed ID: 11087399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.